CVRx | Barostim
Avatar

VAM 2023: Baroreflex Activation Therapy - A Novel Extravascular Procedure for Heart Failure (Discussion)

By CVRx | Barostim FEATURING Clement Darling, MANUEL PEREZ-IZQUIERDO
By CVRx | Barostim FEATURING Clement Darling, MANUEL PEREZ-IZQUIERDO
89 views
August 31, 2023
Dr. R. Clement Darling and Dr. Manuel Perez-Izquierdo Discussion and Q&A from VAM 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

16:18
CVRx | Barostim

ISHLT 2024: Integrating Barostim into a Comprehensive Heart Failure …

Feat. D. Yaranov

Related Videos

12:12
CVRx | Barostim

Challenges and Opportunities with Contemporary GDMT in NYHA Class II…

Feat. W. Abraham
08:30
CVRx | Barostim

Real-World Experience with Baroreflex Activation Therapy: On-the-Job…

Feat. P. Mccann
07:22
CVRx | Barostim

Barostim in HFrEF Patients: International Strategies for Patient Sel…

Feat. J. Bauersachs, P. Wenzel, S. Anker, W. Abraham, P. Mccann
17:08
CVRx | Barostim

Integrating Barostim into a Comprehensive Heart Failure Program ISHL…

Feat. D. Yaranov, P. Patel, R. Gupta, J. Schmitto, E. Chung
16:36
CVRx | Barostim

Beyond BeAT-HF - Real World Experience with Barostim

Feat. P. Patel
11:08
CVRx | Barostim

Integrating Barostim into a Comprehensive Heart Failure Program

Feat. R. Gupta
16:18
CVRx | Barostim

ISHLT 2024: Integrating Barostim into a Comprehensive Heart Failure …

Feat. D. Yaranov
10:21
CVRx | Barostim

Patient Identification and Post-Implant Management within an Advance…

Feat. D. Yaranov
17:33
CVRx | Barostim

Beyond BeAT-HF: Real World Experience with Barostim

Feat. G. Panjrath
15:57
CVRx | Barostim

Long-Term Results of the BeAT-HF Clinical Study

Feat. J. Lindenfeld
13:58
CVRx | Barostim

Challenges and Opportunities with Contemporary GDMT (Dr. Heywood)

Feat. J. Thomas Heywood
11:18
CVRx | Barostim

Barostim and the Window of Opportunity in Class II/III HFrEF Patient…

Feat. G. Panjrath, D. Yaranov, J. Lindenfeld, J. Thomas Heywood
18:36
CVRx | Barostim

Barostim and the Window of Opportunity in Class II/III HFrEF Patient…

Feat. W. Abraham, G. Panjrath, D. Yaranov, P. Mccann
09:58
CVRx | Barostim

Barostim for HFrEF Patients

Feat. P. Mccann
10:18
CVRx | Barostim

New Insights from the BeAT-HF Clinical Study

Feat. W. Abraham
06:16
CVRx | Barostim

Challenges and Opportunities with Contemporary GDMT

Feat. D. Yaranov
12:16
CVRx | Barostim

HFSA 2023: Window of Opportunity – Who and When

Feat. G. Panjrath
16:32
CVRx | Barostim

ESC 2023: BeAT-HF: Long term outcome

Feat. M. Zile
11:49
CVRx | Barostim

ESC 2023: Unmet needs and opportunities with device therapies of HFr…

Feat. W. Abraham
11:43
CVRx | Barostim

ESC 2023: Real-world experience with Baroreflex Activation Therapy

Feat. F. Arribas
AUTOPLAY